Medical care of girls with turner syndrome: Where are we lacking?

Endocrine Practice

Volumn 17, Issue 5, 2011, Pages 747-752

  Nabhan, Zeina M ^a   Eugster, Erica A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN;

ADOLESCENT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CELIAC DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTINUING EDUCATION; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ESTROGEN THERAPY; FEMALE; HEARING TEST; HUMAN; KIDNEY ECHOGRAPHY; KIDNEY EXAMINATION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PATIENT CARE; PRACTICE GUIDELINE; SCREENING TEST; THYROID FUNCTION TEST; TURNER SYNDROME;

ADOLESCENT; CHILD; ECHOCARDIOGRAPHY; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; TURNER SYNDROME;

EID: 80052875223     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11059.OR     Document Type: Article

References (79)

1. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologist, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgi-cal support of the bariatric surgery patient. Endocr Pract. 2008;14(Suppl 1):1-83.
2. International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgical and procedural interventions in the treatment of obese patients with type 2 diabetes. Available at: Http://www.idf.org/web-data/ docs/IDF-Position-Statement-Bariatric-Surgery.pdf. Accessed on April 2, 2011.
3. Runkel N, Colombo-Benkmann M, Hüttl TP. Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis. 2011;26:397-404.
4. Poirier P, Cornier MA, Mazzone T, et al; American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Bariatric surgery and cardiovascular risk factors: A scientific state-ment from the American Heart Association. Circulation. 2011;123:1683-1701.
5. Meining A, Feussner H, Swain P, et al. Natural-orifice transluminal endoscopic surgery (NOTES) in Europe: Summary of the working group reports of the Euro-NOTES meeting 2010. Endoscopy. 2011;43:140-143.
6. Gould J, Ellsmere J, Fanelli R, et al. Panel report: Best practices for the surgical treatment of obesity. Surg Endosc. 2011;25:1730-1740.
7. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4823-4843.
8. Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. American Society for Metabolic and Bariatric Surgery position statement on emergency care of patients with complications related to bariatric surgery. Surg Obes Relat Dis. 2010;6:115-117.
9. Rubino F, Kaplan LM, Schauer PR, Cummings DE; Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251:399-405.
10. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 105: Bariatric surgery and preg-nancy. Obstet Gynecol. 2009;113:1405-1413.
11. SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis. 2009;5:387-405.
12. ASMBS Clinical Issues Committee. ASMBS guideline on the prevention and detection of gastrointestinal leak after gastric bypass including the role of imaging and surgi-cal exploration. Surg Obes Relat Dis. 2009;5:293-296.
13. Emerging Technologies and Clinical Issues Clinical Issues Committees of the ASMBS. American Society Metabolic Bariatric Surgery Position Statement on emerg-ing endosurgical interventions for treatment of obesity. Surg Obes Relat Dis. 2009;5:297-298.
14. International Pediatric Endosurgery Group (IPEG). IPEG guidelines for surgical treatment of extremely obese adolescents. J Laparoendosc Adv Surg Tech A. 2009;19 (Suppl 1):xiv-xvi.
15. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211-2219.
16. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using hemoglobin A1c criteria in the U.S. population in 1988-2006. Diabetes Care. 2010;33:562-568.
17. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235-241.
18. Nguyen NT, Nguyen XM, Lane J, Wang P. Relationship between obesity and diabetes in a US adult population: Find-ings from the National Health and Nutrition Examination Survey, 1999-2006. Obes Surg. 2011;21:351-355.
19. Delling L, Karason K, Olbers T, et al. Feasibility of bariatric surgery as a strategy for secondary prevention in cardiovascular disease: A report from the Swedish Obese Subjects Trial. J Obes. 2010;2010. pii: 102341.
20. Garrett JR, McNolty LA. Bariatric surgery and the social character of the obesity epidemic. Am J Bioeth. 2010;10: 20-22.
21. Liu E, McKeown NM, Newby PK, et al. Cross-sectional association of dietary patterns with insulin-resistant phe-notypes among adults without diabetes in the Framingham Offspring Study. Br J Nutr. 2009;102:576-583.
22. Frezza EE, Wachtel M. Metabolic syndrome: A new mul-tidisciplinary service line. Obes Surg. 2011;21:379-385.
23. Thompson CC. Endoscopic therapy of obesity: A new paradigm in bariatric care. Gastrointest Endosc. 2010;72: 505-507.
24. Fishman E, Melanson D, Lamport R, Levine A. A novel endoscopic delivery system for placement of a duodenal-jejunal implant for the treatment of obesity and type 2 dia-betes. Conf Proc IEEE Eng Med Biol Sci. 2008:2501-2503.
25. Ayloo SM, Buchs NC, Addeo P, Bianco FM, Giulianotti PC. Traditional versus single-site placement of adjustable gastric banding: A comparative study and cost analysis. Obes Surg. 2011;21:815-819.
26. Galvani CA, Choh M, Gorodner MV. Single-incision sleeve gastrectomy using a novel technique for liver retrac-tion. JSLS. 2010;14:228-233.
27. Targarona EM, Maldonado EM, Marzol JA, Marinello F. Natural orifice transluminal endoscopic surgery: The transvaginal route moving forward from cholecystectomy. World J Gastrointest Surg. 2010;2:179-186.
28. Diamantis T, Alexandrou A, Nikiteas N, Giannopoulos A, Papalambros E. Initial experience with robotic sleeve gastrectomy for morbid obesity. Obes Surg. 2011;21: 1172-1179.
29. Edelson PK, Dumon KR, Sonnad SS, Shafi BM, Williams NN. Robotic vs. conventional laparoscopic gas-tric banding: A comparison of 407 cases. Surg Endosc. 2011;25:1402-1408.
30. Ayloo SM, Addeo P, Shah G, Sbrana F, Giulianotti PC. Robot-assisted hybrid laparoscopic Roux-en-Y gas-tric bypass: Surgical technique and early outcomes. J Laparoendosc Adv Surg Tech. 2010;20:847-850.
31. Sudan R, Kasotakis G, Betof A, Wright A. Sleeve gas-trectomy strictures: Technique for robotic-assisted stricture-plasty. Surg Obes Relat Dis. 2010;6:434-436.
32. Bal BS, Finelli FC, Koch TR. Origins of and recognition of micronutrient deficiencies after gastric bypass surgery. Curr Diab Rep. 2011;11:136-141.
33. Granado-Lorencio F, Simal-Antón A, Salazar-Mosteiro J, et al. Time-course changes in bone turnover markers and fat-soluble vitamins after obesity surgery. Obes Surg. 2010:20;1524-1529.
34. Richardson DW, Mason ME, Vinik AI. Update: Meta-bolic and cardiovascular consequences of bariatric surgery. Endocrinol Metab Clin North Am. 2011;40:81-96.
35. Jen M, Yan AC. Syndromes associated with nutritional deficiency and excess. Clin Dermatol. 2010;28:669-685.
36. Fierabracci P, Pinchera A, Martinelli S, et al. Prevalence of endocrine diseases in morbidly obese patients sched-uled for bariatric surgery: Beyond diabetes. Obes Surg. 2011;21:54-60.
37. McClave SA, Mechanick JI, Bistrian B, et al. What is the significance of a physician shortage in nutritional medicine? JPEN J Parenter Enteral Nutr. 2010;34(Suppl 6):7S-20S.
38. McClave SA, Mechanick JI, Kushner RF, et al. Compilation of recommendations from summit on increas-ing physician nutrition experts. JPEN J Parenter Enteral Nutr. 2010;34(Suppl 6):123S-132S.
39. Angrisani L, Favretti F, Furbetta F, et al. Italian group for Lap-Band System: Results of multicenter study on patients with BMI
40. Choi J, Digiorgi M, Milone L, et al. Outcomes of laparo-scopic adjustable gastric banding in patients with low body mass index. Surg Obes Relat Dis. 2010;6:367-371.
41. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gas-tric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA. 2008;299:316-323.
42. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: A randomized trial. 2006;144:625-633.
43. Parikh M, Duncombe J, Fielding GA, et al. Laparoscopic adjustable gastric banding for patients with body mass index of
44. Sultan S, Parikh M, Youn H, Kurian M, Fielding G, Ren C. Early U.S. outcomes after laparoscopic adjustable gas-tric banding in patients with a body mass index less than 35 kg/m2. Surg Endosc. 2009;23:1569-1573.
45. Varela JE, Frey W. Perioperative outcomes of laparoscopic adjustable gastric banding in mildly obese (BMI
46. Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: Mecha-nisms and 2 year outcomes. Ann Surg. 2010;252:966-971.
47. Villamizar N, Pryor AD. Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus. J Obes. 2011 [epub ahead of print].
48. Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. Sleeve gastrectomy and type 2 diabetes mellitus: A system-atic review. Surg Obes Relat Dis. 2010;6:707-713.
49. Maciejewski ML, Livingston EH, Kahwati LC, Henderson WG, Kavee AL, Arterburn DE. Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers. Surg Obes Relat Dis. 2010;6:601-607.
50. Hamza N, Abbas MH, Darwish A, Shafeek Z, New J, Ammori BJ. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis. 2010 [epub ahead of print].
51. de Sa VC, Ferraz AA, Campos JM, Ramos AC, Araujo Jr. JG, Ferraz EM. Gastric bypass in the treatment of type 2 diabetes in patients with a BMI of 30 to 35 kg/m2. Obes Surg. 2011;21:283-287.
52. Hoerger TJ, Zhang P, Segel JE, Kahn HS, Barker LE, Couper S. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010; 33:1933-1939.
53. Klein S, Ghosh A, Cremieux PY, Eapen S, McGavock TJ. Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI =35 kg/m2. Obesity (Silver Spring). 2011;19:581-587.
54. Hofsø D, Jenssen T, Bollerslev J, et al. Beta cell func-tion after weight loss: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2011;164:231-238.
55. Woods M, Lan Z, Li J, Wheeler MB, Wang H, Wang R. Antidiabetic effects of duodenojejunal bypass in an experi-mental model of diabetes induced by a high-fat diet. Br J Surg. 2011;98:686-696.
56. Alam ML, Van der Schueren BJ, Ahren B, et al. Gastric bypass surgery, but not caloric restriction, decreases dipep-tidyl peptidase-4 activity in obese patients with type 2 dia-betes. Diabetes Obes Metab. 2011;13:378-381.
57. Deitel M. Update: Why diabetes does not resolve in some patients after bariatric surgery. Obes Surg. 2011;21:794-796.
58. Rubino F, Kaplan LM, Schauer PR, Cummings DE; Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251:399-405.
59. 2nd World Congress on Interventional Therapies for Type 2 Diabetes. March 28-30, 2011, Hilton New York, New York, NY. Available at: Http://wcidt.org/ Accessed April 2, 2011.
60. Handelsman Y, Mechanick JI, Blonde L, et al; AACE Task Force for Developing Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17(Suppl 2):1-53.
61. Boza C, Muñoz R, Yung E, Milone L, Gagner M. Sleeve gastrectomy with ileal transposition (SGIT) induces a sig-nificant weight loss and diabetes improvement without exclusion of the proximal intestine. J Gastrointest Surg. 2011;15:928-934.
62. de Moura EGH, Orso IR, Martins Bda C, et al. Improvement of insulin resistance and reduction of car-diovascular risk among obese patients with type 2 diabe-tes with the duodenojejunal bypass liner. Obes Surg. 2011; 21:941-947.
63. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559.
64. James WP, Caterson ID, Coutinho W, et al; SCOUT Investigators. Effect of sibutramine on cardiovascular out-comes in overweight and obese subjects. N Engl J Med. 2010;363:905-917.
65. Goitein D, Feigin A, Segal-Lieberman G, Goitein O, Papa MZ, Zippel D. Laparoscopic sleeve gastrectomy as a revisional option after gastric band failure. Surg Endosc. 2011;25:2626-2630.
66. Parikh M, Heacock L, Gagner M. Laparoscopic "gastro-jejunal sleeve reduction" as a revision procedure for weight loss failure after Roux-en-Y gastric bypass. Obes Surg. 2011;21:650-654.
67. Leyba JL, Aulestia SN, Llopis SN. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. A prospective study of 117 patients. Obes Surg. 2011;21:212-216.
68. de Gordejuela AG, Pujol Gebelli J, García NV, Alsina EF, Medayo LS, Masdevall Noguera C. Is sleeve gastrec-tomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients? Surg Obes Relat Dis. 2011;7:506-509.
69. Lacy A, Ibarzabal A, Pando E, et al. Revisional surgery after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech. 2010;20:351-356.
70. Triantafyllidis G, Lazoura O, Sioka E, et al. Anatomy and complications following laparoscopic sleeve gastrec-tomy: Radiological evaluation and imaging pitfalls. Obes Surg. 2011;21:473-478.
71. D'Hondt M, Vanneste S, Pottel H, Devriendt D, Van Rooy F, Vansteenkiste F. Laparoscopic sleeve gastrec-tomy as a single-stage procedure for the treatment of mor-bid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc. 2011;25:2498-2504.
72. Karcz WK, Marjanovic G, Grueneberger J, et al. Banded sleeve gastrectomy using the GaBP ring-surgical technique. Obes Facts. 2011;4:77-80.
73. Shi X, Karmali S, Sharma AM, Birch DW. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2010;20:1171-1177.
74. Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2006;10:1033-1037.
75. Faintuch J, Matsuda M, Cruz ME, et al. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg. 2004;14:175-181.
76. Clements RH Katasani VG, Palepu R, et al. Incidence of vitamin deficiency after laparoscopic Roux-en-Y gas-tric bypass in a university hospital setting. Am Surg. 2006;72:1196-1202.
77. de Luis DA, Pacheco D, Izaola O, Terroba MC, Cuellar L, Martin T. Clinical results and nutritional consequences of biliopancreatic diversion: Three years of follow-up. Ann Nutr Metab. 2008;53:234-239.
78. Weiss AJ, Iqbal J, Zaidi N, Mechanick JI. The skeletal subsystem as an integrative physiology paradigm. Curr Osteoporos Rep. 2010;8:168-177.
79. Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. Corticotropin- releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA. 1993;269:2232-2238.